CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype-phenotype correlation in Turkish children

Firdevs Baş, Hülya Kayserili, Feyza Darendelıler, Zehra Oya Uyguner, Hülya Günöz, Memnune Yüksel Apak, Fatmahan Atalar, Rüveyde Bundak, Robert C. Wilson, Maria I. New, Bernd Wollnik, Nurçin SakaJournal of Clinical Research in Pediatric Endocrinology 2009 · DOI

TL;DR

This study investigates the genetic basis of Congenital Adrenal Hyperplasia (CAH) in Turkish children, identifying common mutations in the CYP21A2 gene and exploring the relationship between these genetic variations (genotype) and the resulting clinical symptoms (phenotype). The findings provide a crucial foundation for developing targeted genetic screening and improved patient care strategies within the Turkish population.

What Problem Does This Paper Address?

Congenital Adrenal Hyperplasia (CAH) is a group of genetic disorders affecting the adrenal glands, most commonly caused by deficiencies in the 21-hydroxylase enzyme, which is encoded by the CYP21A2 gene. This deficiency leads to an imbalance in hormone production, with reduced cortisol and aldosterone and increased androgen levels. CAH manifests in different forms, primarily the severe "classical" forms (salt-wasting and simple virilizing) and the milder "non-classical" form. While the genetic basis of CAH is well-established, understanding the specific mutations and their correlation with clinical presentation is vital for accurate diagnosis, prognosis, and management. This paper addresses the need for a comprehensive molecular characterization of CAH in the Turkish population, aiming to establish genotype-phenotype correlations and inform local healthcare practices.

Methods

The researchers employed a multi-pronged approach to analyze the CYP21A2 gene in 56 Turkish children diagnosed with CAH.

  • Molecular Analysis: They screened for eight common point mutations, large deletions, and gene conversions within the CYP21A2 gene. This involved a combination of techniques:
  • Allele-specific semi-quantitative PCR/enzyme restriction: Used to detect specific mutations and quantify their presence.
  • Southern blotting: Employed for the detection of large deletions and conversions.
  • Sequencing: Utilized for patients with only one identified affected allele to detect additional mutations.
  • Phenotypic Assessment: Patients were clinically and hormonally evaluated to categorize them into salt-wasting (SW), simple virilizing (SV), or non-classical (NC) forms of CAH.
  • Statistical Analysis: Standard statistical methods, including nonparametric tests and Spearman's correlation, were used to compare means and analyze relationships between variables. Chi-square tests were applied to compare mutation distributions across clinical types.

Datasets

The study utilized blood samples from 56 affected patients across 52 Turkish families. No new benchmarks or datasets were introduced; the focus was on analyzing the genetic makeup of this specific patient cohort.

Key Insights and Ideas

  • First Comprehensive Study in Turkey: This paper represents the initial in-depth molecular investigation of CAH in the Turkish population, filling a significant knowledge gap.
  • High Mutation Detection Rate: The study successfully identified disease-causing mutations in a substantial proportion (84.6%) of the analyzed alleles, indicating the effectiveness of their screening methods.
  • Genotype-Phenotype Correlation: A strong correlation between genetic mutations and clinical presentation was observed, particularly in the salt-wasting (SW) and non-classical (NC) forms. This reinforces the predictive power of genetic testing.
  • Proposed Screening Strategy: Based on their findings, the authors suggest a modified screening strategy tailored to the Turkish population, which could streamline molecular testing and improve diagnostic efficiency.
  • Ethnic Specificity: While many common mutations are shared globally, the study highlights the importance of understanding population-specific mutation frequencies for effective genetic screening.

Key Results

  • Disease-causing mutations were identified in 77 out of 91 alleles (84.6%) across all CAH forms.
  • Mutation detection rates varied by phenotype: 79.1% in SW, 88.8% in SV, and 91.6% in NC forms.
  • The most frequent mutations observed were IVS-2 (22.0%), large conversion (14.3%), p.1172N (9.9%), and p.R356W (8.8%).
  • In SW patients, homozygous IVS-2 and homozygous large conversion were the most common genotypes.
  • In SV patients, homozygous IVS-2 was most frequent, followed by compound heterozygous p.1172N/8-bp del.
  • Homozygous p.V281L was the most common genotype in NC patients.
  • Good genotype-phenotype correlation was observed in SW and NC forms for all patients. However, in the SV form, 5 out of 24 patients showed genotypes predicting the NC form, and two siblings with SV had genotypes predicting the SW form, indicating some exceptions.

Limitations and Future Work

  • Undetected Mutations: A portion of alleles (15.4%) remained with undetected mutations, suggesting the existence of rarer or novel mutations not covered by the screening panel.
  • Non-Classical CAH Phenotype Variability: While a general correlation was found, some patients with non-classical CAH exhibited phenotypic variability, suggesting the influence of other genetic or environmental factors.
  • Future Directions: The authors propose implementing their modified screening strategy for the Turkish population. They also emphasize the importance of this data for prenatal diagnosis, genetic counseling, and carrier detection, ultimately aiming to improve patient care and management of CAH.

Summary updated

Abstract

This is the first comprehensive study on the molecular basis of CAH patients in the Turkish population. Based on these results, we propose a modified screening strategy to facilitate molecular testing of CAH patients in our population.
BibTeX
@article{bas2009cyp,
  author = {Firdevs Baş and Hülya Kayserili and Feyza Darendelıler and Zehra Oya Uyguner and Hülya Günöz and Memnune Yüksel Apak and Fatmahan Atalar and Rüveyde Bundak and Robert C. Wilson and Maria I. New and Bernd Wollnik and Nurçin Saka},
  title = {{CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype-phenotype correlation in Turkish children}},
  journal = {Journal of Clinical Research in Pediatric Endocrinology},
  year = {2009},
  doi = {10.4008/jcrpe.v1i3.49},
}
Figure